With Congress weighing insulin cost cap, Sanofi slashes price for uninsured in US

With Congress weighing a cap on out-of-pocket costs for insulin for certain individuals, Sanofi has beaten the government to the punch.

The Paris-based company says it will slash the price of its fleet of insulin products to uninsured residents of the U.S. from $99 per month to $35.